Trifunctional Protein Deficiency Clinical Trial
Official title:
Fatty Acid Oxidation Disorders & Body Weight Regulation
Several hormones involved in body weight regulation increase the subject's ability to burn fat for energy. The purpose of this study is to investigate how burning fat for energy may affect those hormones and body weight in children. The study will also determine if eating a diet higher in protein alters the amount of fat you burn and how these hormones control body weight.
A role for mitochondrial fatty acid oxidation in the peripheral signaling cascade of leptin,
adiponectin and insulin has recently been proposed from animal studies but has not been
investigated in humans. Children with trifunctional protein (TFP, including deficiency of
long-chain hydroxyacyl-CoA dehydrogenase) and very long-chain acyl-CoA dehydrogenase (VLCAD)
deficiency, inherited disorders of long-chain fatty acid ß-oxidation, lack an ability to
oxidize fatty acids for energy. They have increased levels of body fat and circulating
leptin and a high incidence of obesity. Current therapy for children with these disorders is
based on frequent meals and consuming a low fat, very high carbohydrate diet. Despite
treatment, exercise induced rhabdomyolysis is a common complication of TFP and VLCAD
deficiency that frequently leads to exercise avoidance. The effects of these genetic defects
on body composition and weight regulation have not been investigated. The contribution of
fatty-acid oxidation during moderate intensity exercise in children has also not been
reported.
Two groups of subjects were recruited: one group of subjects had a long-chain fatty acid
oxidation disorder (n=13). The other group is a group of controls (n=16). We studied
peripheral signals of body weight regulation, glucose tolerance, body composition, and
exercise metabolism in subjects with a long-chain fatty acid oxidation disorder compared to
normal controls.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01494051 -
High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02517307 -
Fatty Acid Oxidation Defects and Insulin Sensitivity
|
N/A | |
Completed |
NCT05411835 -
Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders
|
Early Phase 1 |